HOW I TREAT PH+ ACUTE LYMPHOBLASTIC LEUKEMIA
The greatest improvements in the management of Acute Lymphoblastic Leukemia (ALL) have been witnessed in Ph+ALL patients. The advancements have stemmed from an always more precise genetic characterization at presentation, the use of tailored treatment, the precise monitoring of minima/Measurable Res...
Saved in:
| Main Author: | Robin Foà |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137925001373 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanism of action of decitabine in treating acute lymphoblastic leukemia
by: Xiaohui Gao, et al.
Published: (2025-07-01) -
Acute Neurotoxicity in Children Treated for Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: A 10-Year Single-Centre Experience
by: Izabela Kranjčec, et al.
Published: (2024-12-01) -
Acute lymphoblastic leukemia and toxoplasmosis
by: G Hiçsönmez, et al.
Published: (1979-01-01) -
Acute lymphoblastic leukemia in infants
by: Aytemiz Gürgey, et al.
Published: (2004-04-01) -
Acute lymphoblastic leukemia in children
by: M. A. Maschan, et al.
Published: (2022-11-01)